These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1707498)

  • 1. [Intratumoral injection of OK-432 in conjunction with fibrinogen greatly enhances antitumor effect on colorectal carcinomas].
    Monden T; Morimoto H; Murotani M; Yagyu T; Nagaoka H; Shimano T; Mori T
    Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):31-6. PubMed ID: 1707498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of fibrinogen to enhance the antitumor effect of OK-432. A new approach to immunotherapy for colorectal carcinoma.
    Monden T; Morimoto H; Shimano T; Yagyu T; Murotani M; Nagaoka H; Kawasaki Y; Kobayashi T; Mori T
    Cancer; 1992 Feb; 69(3):636-42. PubMed ID: 1370392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].
    Takeda T; Wakasugi T; Katsumoto Y; Sakita I; Nagaoka H; Morimoto H; Tsujinaka T; Monden T; Shiozaki H; Shimano T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1458-60. PubMed ID: 1530293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of urokinase-type plasminogen activator in local immunotherapy.
    Takeda T; Ito Y; Wakasugi E; Kobayashi T; Monden M
    Oncol Rep; 1998; 5(2):329-33. PubMed ID: 9468551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
    Hosokawa T
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):577-86. PubMed ID: 1831533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages.
    Takeda T; Kobayashi T; Monden T; Katsumoto Y; Ito Y; Wakasugi E; Wakasugi T; Tomita N; Shimano T; Mori T
    Biotherapy; 1993; 7(1):47-54. PubMed ID: 8068483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local injection of OK-432/fibrinogen gel into head and neck carcinomas.
    Kumazawa H; Yamashita T; Tachikawa T; Minamino M; Nakata Y
    Eur J Cancer; 1994; 30A(12):1741-4. PubMed ID: 7880597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Locoregional injection of OK-432/fibrinogen/thrombin for unresectable metastatic liver tumors].
    Yoshida T; Osato H; Sakon M; Monden T; Amano M; Aoki T; Kishimoto S; Umeshita K; Dono K; Gotoh M; Monden M
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1575-7. PubMed ID: 8854809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective augmentations of intratumoral 5-fluorouracil concentration by local immunotherapy with OK-432 and fibrinogen.
    Amano M; Sekimoto M; Monden T; Tomita N; Ohue M; Haba A; Sakita I; Tamaki Y; Monden M
    Dis Colon Rectum; 2000 Mar; 43(3):402-7. PubMed ID: 10733124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that eosinophil infiltration in the OK-432/fibrinogen-injected Meth-A tumor in mice is mediated by locally produced IL-5.
    Ishiko T; Sakamoto K; Mita S; Kamohara H; Ogawa M
    Int J Immunopharmacol; 1997 Jul; 19(7):405-12. PubMed ID: 9568545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors].
    Akimoto M; Nishihira T; Hirakawa H; Abe M; Ohuchi N; Mori S; Kumagai K
    Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):64-74. PubMed ID: 2014029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A patient with unresectable cancer of pancreas head, effectively treated by a local injection of the mixture of OK-432, fibrinogen and thrombin].
    Takekuni K; Sakon M; Kishimoto S; Amano M; Sekimoto M; Aoki T; Oosato H; Dohno K; Umeshita K; Gotoh M; Monden T; Monden M
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1621-3. PubMed ID: 8854822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between anti-tumor effect and delayed hypersensitivity induced by topically applied OK-432 with histological findings].
    Kokunai I; Mori T; Yayoi E; Matuura N; Kosaki G
    Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):258-65. PubMed ID: 3982380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of bronchial carcinoma showing regression upon intratumoral administration of OK-432].
    Onodera A; Miura K; Sasaki M; Sugiyama N; Kurokawa H; Shioya T; Kanazawa T
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):341-4. PubMed ID: 3341793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
    Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
    No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].
    Mitachi Y; Murakawa Y; Okuno M; Kambe M; Kanamaru R; Takahasi H; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):482-8. PubMed ID: 2138871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
    Obi Y
    Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local immunotherapy for cancer].
    Hattori T; Niimoto M; Toge T; Hamamoto S; Seto Y; Kameda A; Tomoda S
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1157-61. PubMed ID: 6503978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endoscopic fistula therapy using a fibrin glue].
    Jung M; Brands W; Manegold BC
    Schweiz Rundsch Med Prax; 1988 Jan; 77(1-2):3-5. PubMed ID: 2449718
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). I. Sequential effector mechanisms following a single OK-432 injection in F344 rats leading to the rejection of syngeneic MADB106 tumor cells.
    Fukui H; Reynolds CW
    J Natl Cancer Inst; 1987 Nov; 79(5):1011-7. PubMed ID: 3479632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.